v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Apr. 03, 2026
Apr. 04, 2025
Statement of Cash Flows [Abstract]    
Net income $ 210,467 $ 159,616
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,948 7,345
Stock-based compensation 29,050 25,930
Non-cash lease expense 5,994 6,096
Acquired in-process research and development technology 2,025 0
Other, net (2,019) (4,786)
Changes in operating assets and liabilities:    
Trade receivables, net (42,031) (16,119)
Inventory (3,389) (71)
Prepaid expenses and other assets 58,653 20,320
Accrued collaboration liabilities 4,044 4,605
Accounts payable and other liabilities (17,897) 8,501
Net cash provided by operating activities 251,845 211,437
Cash flows from investing activities:    
Purchases of marketable securities (274,161) (186,701)
Proceeds from maturities and sales of marketable securities 225,125 258,917
Purchases of property, equipment and other, net (1,509) (2,952)
Acquired in-process research and development technology (525) (19,500)
Net cash provided by (used in) investing activities (51,070) 49,764
Cash flows from financing activities:    
Payments for repurchases of common stock (430,352) (283,934)
Proceeds from issuance of common stock under the equity incentive plan 7,472 11,627
Taxes paid related to net share settlement of equity awards (34,231) (22,516)
Net cash used in financing activities (457,111) (294,823)
Net decrease in cash and cash equivalents (256,336) (33,622)
Cash and cash equivalents at beginning of period 482,488 217,374
Cash and cash equivalents at end of period $ 226,152 $ 183,752